Personalized Search
Displaying 501 - 520 of 995
Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.
Bio last updated
.
Node ID (debugging only): 101
Dr. Tabbara has researched blood and
bone marrow
bone marrow:
The soft, spongy tissue inside most bones. Blood cells are formed in the bone marrow.
stem cell transplant. He established the
bone marrow transplant
bone marrow transplant:
A bone marrow transplant (BMT) is also called a stem cell transplant (SCT) or hematopoietic stem cell transplant (HSCT).The procedure…
Bio last updated
.
Node ID (debugging only): 160
Dr. Ivana Gojo is a
Hematologist
Hematologist:
(hee-muh-TOL-uh-jist) A doctor who specializes in treating blood diseases and disorders of blood producing organs.
/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic…
Bio last updated
.
Node ID (debugging only): 265
Dr. Grunwald is board certified in internal medicine, hematology and medical oncology. He specializes in hematology-oncology (cancer and blood disorders).
He has clinical interests in acute and chronic leukemias, including myelodysplastic syndrome and myeloproliferative neoplasms, transplantation and cellular therapy.
He is chief of the Leukemia Division at Atrium Health’s Levine Cancer…
Bio last updated
.
Node ID (debugging only): 425
Dr. Becker is pursuing several areas of research investigation, including 1) the mechanism of adhesion mediated
chemotherapy
chemotherapy:
(kee-moe-THER-uh-pee) The use of medicines that kill cells (cytotoxic agents). People with high-risk or intermediate-2 risk myelodysplastic syndrome (MDS) may be given chemotherapy to kill bone marrow cells that have an abnormal size, shape, or look…
Bio last updated
.
Node ID (debugging only): 3
Dr. Ellen Friedman has been the Hematology Fellowship Director of Montefiore Medical Center/Albert Einstein College of Medicine since 2005. She completed a fellowship in hematology at New York University, specializing in the conditions of red cells, platelets and hematologic malignancies. She has been engaged in diagnosing and treating these conditions while simultaneously teaching medical…
Bio last updated
.
Node ID (debugging only): 88
Dr. Josh Sasine is a
hematologist
hematologist:
(hee-muh-TOL-uh-jist) A doctor who specializes in treating blood diseases and disorders of blood producing organs.
and
oncologist
oncologist:
(on-KAH-luh-jist) A doctor who specializes in the treatment and prevention of cancer.
at UCLA specializing in the treatment of hematologic malignancies, including hematopoietic stem cell…
Bio last updated
.
Node ID (debugging only): 151
Earlier this summer, AAMDSIF called for research proposals addressing
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria:
(par-uk-SIZ-muhl nok-TURN-uhl hee-muh-gloe-buh-NYOOR-ee-uh) A rare and serious blood disease that causes red blood cells to break apart. Paroxysmal means sudden and irregular. Nocturnal means at night. Hemoglobinuria means hemoglobin in the…
Bio last updated
.
Node ID (debugging only): 76
Matt Kalaycio, MD, FACP, is the former Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic Taussig Cancer Institute. Dr. Kalaycio is also a Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Board-certified in hematology, Dr. Kalaycio's clinical interests are in leukemia and hematopoietic cell…
Bio last updated
.
Node ID (debugging only): 228